Search for...

Greek-founded Brainomix raised over €18M to scale its AI solution and support physicians treat cancer and lung fibrosis

Brainomix
Image credit: Brainomix
, ~

British MedTech startup Brainomix, which has a Greek co-founder, raised over €18M in a Series B, to scale its AI-based solution. In almost a decade since the launch, it has raised over €30M in over six rounds. Brainomix is working on creating imaging biomarkers. The team is developing a precision medicine solution that aims to help health practitioners offer personalized treatments. 

“When we started our venture with Brainomix, AI-powered decision support technologies were still at a very early stage and the physicians/radiologists were skeptical about its utility. We had to invest in generating clinical evidence to show that more patients get treated when physicians use our technologies. Now – especially in the last year, probably accelerated by the pandemic – AI has become broadly accepted in medical diagnosis, as a way to support (not replace!) physicians,” Michalis Papadakis, co-founder and CEO of Brainomix, shared with The Recursive

The e-Stroke platform has been used for over 600K patients in 300 hospitals from 30 countries in Europe, the US, South America, and Asia. It has proved to encourage faster treatment which improves functional independence in stroke patients. 

With this new round, they aim to tackle lung fibrosis and cancer solutions, after they initially focused on strokes. The team will target clinical trials to achieve broader adoption and develop their team at Oxford as well as globally.

How can AI help MedTech?

“We were seeing a big unmet need globally, with millions of patients missing out on life-saving stroke treatments because they were admitted in hospitals that didn’t have the right experience and expertise to reliably diagnose and treat these patients. We had the idea of using Artificial Intelligence to automate the analysis of brain CT scans of stroke patients and support front-line physicians to make confident diagnosis and treatment decisions,” Michalis Papadakis says.

The MedTech was developed in 2012 as a spin-out from the University of Oxford by Michalis Papadakis, co-founder and CEO, and Andrew Barker. Papadakis has a background in biochemistry, neuroscience, and medical innovation, while Barker has experience with marketing, management, and engineering. 

Read more:  BeAI pre-accelerator 2021 winners want to see the establishment of ethical AI

Papadakis shared that they began by building the team, then the AI technology. The next developing phase boosted by persistence and innovation was validating the technology to ensure it is accurate and robust, followed by generating broad clinical adoption. Then, the startup received the ICT award of the Academic Enterprise Awards.

The CEO says they will remain focused on delivering solutions that address unmet needs. In a 2015 study, conducted by the American Thoracic Society, there were over 5M patients with idiopathic pulmonary fibrosis, with a mortality rate of 50% in 3-5 years after diagnosis; while another study shows that in 2018 there were estimated 18M cancer cases around the world. 

Thank you for reading The Recursive!

Over 1 million people from all over the world have learned about the tech ecosystem in Central and Eastern Europe thanks to The Recursive. In order to keep our content free for everyone, we need your help. If you believe what we do is important and have the means to do so, support us in giving a voice to Central and Eastern Europe with as little as €7. Thank you!

DONATE Keep reading this article

Help us grow the emerging innovation hubs in Southeast Europe

Every single contribution of yours helps us guarantee our independence and sustainable future. With your financial support, we can keep on providing constructive reporting on the developments in the region, give even more global visibility to our ecosystem, and educate the next generation of innovation journalists and content creators.

Find out more about how your donation could help us shape the story of the SEE entrepreneurial ecosystem!

One-time donation

You can also support The Recursive’s mission with a pick-any-amount, one-time donation. 👍

Elena is an Innovation Reporter at The Recursive with 10+ years of experience as a freelance writer based in Bucharest, Romania. Her mission is to report internationally on the amazing progress of the local startup ecosystem while bringing into focus topics such as diversity in business cultures and women in tech; mental health, work-life balance, and the future. Of what? Everything! As a former solopreneur and a full-time mom, she strives to learn something new every day to share with the world. #nevernotlearning
Startups